Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 54 Neoplasms 38 Lung Neoplasms 24 Colorectal Neoplasms 24 Prostatic Neoplasms 17 Uterine Cervical Neoplasms 14 Motor Activity 13 Colonic Neoplasms 11 Carcinoma, Non-Small-Cell Lung 10 Rectal Neoplasms 9 Pancreatic Neoplasms 9 Hematologic Neoplasms 9 Anxiety Disorders 9 Urinary Bladder Neoplasms 8 Obesity 8 Melanoma 8 Lymphoma 8 Depression 8 Ovarian Neoplasms 7 Endometrial Neoplasms 7 Vulvar Neoplasms 6 Neoplasm Metastasis 6 Head and Neck Neoplasms 6 Breast Carcinoma In Situ 6 Sarcoma 5 Papillomavirus Infections 5 Pain 5 Leukemia, Myeloid, Acute 5 Hematopoietic and Lymphatic System Neoplasm 5 Triple Negative Breast Neoplasms 4

Interventions

Cyclophosphamide 38 Paclitaxel 22 Epirubicin 21 Trastuzumab 20 Docetaxel 20 Doxorubicin 19 Carboplatin 15 Radiotherapy 13 Taxes 11 Filgrastim 11 Neoadjuvant Therapy 9 Bevacizumab 9 Fluorouracil 8 pembrolizumab 7 Tamoxifen 7 Albumin-Bound Paclitaxel 7 Capecitabine 6 pertuzumab 5 Thiotepa 5 Peripheral Blood Stem Cell Transplantation 5 Lapatinib 5 130-nm albumin-bound paclitaxel 5 pegfilgrastim 4 Granulocyte Colony-Stimulating Factor 4 Cisplatin 4 Chemotherapy, Adjuvant 4 Biopsy 4 tipifarnib 3 eribulin 3 Surgical Procedures, Operative 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Inflammatory Breast Neoplasms × Methods × Clear all

NCT07474090 2026-03-16

STEPS-BC

Wake Forest University Health Sciences

Phase NA Not yet recruiting

Breast Neoplasms, Inflammatory Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡